NSE ScannerComparison · NSE · data 2026-11-01
Anthem Biosciences Limited vs Fabtech Technologies Limited
In plain words
Size: Anthem Biosciences Limited is about 85.4 times the market value of Fabtech Technologies Limited.
Valuation (P/E): Anthem Biosciences Limited 81.7 vs Fabtech Technologies Limited 14.1.
Return on equity: Anthem Biosciences Limited 21.7% vs Fabtech Technologies Limited 12.9%.
Profit growth over 3 years: Fabtech Technologies Limited 20.8% a year vs Anthem Biosciences Limited 15.4% a year.
Debt to equity: Fabtech Technologies Limited 0.17 vs Anthem Biosciences Limited 0.02.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ANTHEM | FABTECH | |
|---|---|---|
| Price | ₹828.8 | ₹123.9 |
| Market cap | ₹46,685 cr | ₹547 cr |
| P/E | 81.7 | 14.1 |
| P/B | — | 1.3 |
| ROE | 21.7% | 12.9% |
| ROCE | 26.0% | 9.1% |
| Debt / equity | 0.02 | 0.17 |
| Operating margin | 32.7% | 5.1% |
| Dividend yield | 0.24% | 0.49% |
| Sales growth, 3 years (yearly) | 26.2% | 29.2% |
| Profit growth, 3 years (yearly) | 15.4% | 20.8% |
| 1-year return | 13.6% | -48.7% |
| Revenue, last 12 months | ₹2,002 cr | ₹388 cr |
| Net profit, last 12 months | ₹576 cr | ₹36 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹120 cr | ₹15 cr |
| Quarter profit vs a year earlier | -11.7% | -46.6% |
| Promoter holding | 71.40% | 69.03% |
| Health check | Average (5.8/10) | Average (5.6/10) |
Common questions
Which has a higher P/E, Anthem Biosciences Limited or Fabtech Technologies Limited?
Anthem Biosciences Limited trades at the higher P/E (81.7 against 14.1). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Anthem Biosciences Limited (21.7% against 12.9%).
Which carries more debt?
Fabtech Technologies Limited has the higher debt-to-equity ratio (0.17 against 0.02).